Lilly's first Phase 3 readout (TRIUMPH4) reported strong results in people with obesity/overweight and knee osteoarthritis, including: ~28.7% average weight loss at 68 weeks at the 12 mg dose (topline reporting), plus improvements in pain and function measures The important phrase there is "topline"
It has been used in medical research for some time and is being studied as a potential treatment for conditions such as Parkinsons Disease, brain injury, wound healing, and joint health
Special considerations for different thyroid conditions Hashimoto thyroiditis Patients with Hashimoto disease represent the largest group of people on levothyroxine who might consider tirzepatide
How should DSIP peptide be stored after reconstitution
Furderer S, Wenda K, Thiem N, Hachenberger R, Eysel P
PubMed laboratory research record [PMID: 32233230] PubMed record related to this compound for laboratory literature review